摘要 |
Compounds that are dual aP2/k-FABP inhibitors are provided having the formula (I), wherein A, B, X, Y, R<1>, R<2> and R<3> are as described herein. A method is also provided for treating diabetes and related diseases, especially Type II diabetes, employing dual aP2/k-FABP inhibitors alone or in combination with at least one other antidiabetic agent such as metformin, glyburide, troglitazone and/or insulin. |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY;MAGNIN, DAVID, R.;SULSKY, RICHARD, B.;ROBL, JEFFREY, A.;CAULFIELD, THOMAS, J.;PARKER, REX, A. |
发明人 |
MAGNIN, DAVID, R.;SULSKY, RICHARD, B.;ROBL, JEFFREY, A.;CAULFIELD, THOMAS, J.;PARKER, REX, A. |